|
|
|
|
|||||
|
|
|
Zoetis Inc. (NYSE:ZTS) is one of the Good Stocks to Buy According to Analysts. On December 2, Zoetis Inc. (NYSE:ZTS) held its innovation day, highlighting its long-term growth opportunities. In addition, Wall Street maintains a positive outlook on the stock.
Management noted that the animal health market is anticipated to grow nearly double the current size to $90 billion by 2035. This is pertinent for the company as its pipeline includes 12 candidates with blockbuster potential treating chronic kidney disease, oncology, and cardiology. Management added that this represents more than $5 billion in total addressable market opportunity for the company.
Following the announcement on December 2, Brandon Vazquez from William Blair reiterated a Buy rating on Zoetis Inc. (NYSE:ZTS) without disclosing any price target. Earlier on December 1, Michael Ryskin from Bank of America Securities also reiterated a Buy rating on the stock, but lowered the price target from $200 to $165.
Brandon Vazquez of William Blair noted that the updates provided by Zoetis Inc. (NYSE:ZTS) on the innovation day suggest that the company’s innovation engine is robust. He added that this overshadows the setback of underperforming Librela in 2025. Moreover, the analyst also likes the company’s valuation at 18.5 times its 2026 forward earnings. Vazquez noted that the company’s stock might remain stable in the short term, but once the pipeline starts to mature, he anticipates a favorable risk/reward situation in the long term.
Zoetis Inc. (NYSE:ZTS) is a leading global animal health company, focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, biodevices, genetic tests, and precision health solutions.
While we acknowledge the potential of ZTS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
| Dec-09 |
How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025
ZTS
Investor's Business Daily
|
| Dec-09 | |
| Dec-05 | |
| Dec-04 | |
| Dec-04 | |
| Dec-04 | |
| Dec-02 | |
| Dec-01 | |
| Nov-26 | |
| Nov-25 | |
| Nov-25 | |
| Nov-21 | |
| Nov-20 | |
| Nov-19 | |
| Nov-19 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite